Milestone Scientific Inc. (MLSS) Stock Forecast
MLSS analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $1.25 average of analyst targets
- Upside to target
- +282.8% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-0.01
- 52-week range
- $0.25 – $0.55
MLSS analyst ratings
2 analystsNumber of analysts at each rating.
MLSS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MLSS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.01 | −$0.01 | −$0.01 | −$0.01 | 0.0% | 2 |
| Current fiscal year (2026) | −$0.04 | −$0.04 | −$0.04 | −$0.07 | +42.9% | 2 |
| Next fiscal year (2027) | −$0.04 | −$0.04 | −$0.03 | −$0.04 | +12.5% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MLSS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.4M | $2.3M | $2.5M | +2.0% | 2 |
| Current fiscal year (2026) | $10.0M | $9.8M | $10.1M | +11.1% | 2 |
| Next fiscal year (2027) | $11.4M | $10.8M | $11.9M | +13.8% | 2 |
MLSS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MLSS revenue: reported and forecast
MLSS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.01 | −$0.01 | −$0.01 | −$0.01 | −$0.01 | 0.0% | 0 up · 0 down |
| Current fiscal year (2026) | −$0.04 | −$0.04 | −$0.04 | −$0.04 | −$0.04 | 0.0% | 0 up · 1 down |
| Next fiscal year (2027) | −$0.04 | −$0.04 | −$0.04 | −$0.04 | −$0.04 | 0.0% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MLSS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MLSS beat in 6 of 12.
What analysts expect from MLSS
2 analysts cover Milestone Scientific; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $1.25, 282.8% above the latest close of $0.33. Analysts expect earnings of −$0.04 per share for 2026, +42.9% from a year earlier. For 2027 the average estimate is −$0.04 per share on revenue of $11.4 million. Milestone Scientific beat the EPS estimate in 6 of the last 12 quarters.
Related: MLSS income statement, MLSS key metrics, MLSS chart. See the MLSS stock overview for the latest quote and news.
MLSS forecast FAQ
What is Milestone Scientific's price target?
The average analyst price target for Milestone Scientific is $1.25, 282.8% above the latest close of $0.33.
Is Milestone Scientific a buy, hold or sell?
Of 2 analysts covering Milestone Scientific, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Milestone Scientific's EPS forecast?
Analysts forecast −$0.04 per share for 2026 (range −$0.04 to −$0.04); for 2027 the estimate is −$0.04.
What is Milestone Scientific's revenue forecast?
The average revenue estimate for 2026 is $10.0 million, growth of 11.1%; for 2027 it is $11.4 million.
When does Milestone Scientific report earnings?
Milestone Scientific is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $-0.01.
Does Milestone Scientific usually beat earnings estimates?
Milestone Scientific reported EPS at or above the analyst estimate in 6 of the last 12 quarters.